US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quasi-New Stocks

728.40

-5.1492-0.70%

Number of Gainers:64

Number of Losers:112

Number of Flat:10

PE:- -

High:740.89

Open:733.56

Low:721.57

Close:733.55

Loading ...

Bridge Investment Group Engages J.P. Morgan and Lazard for Strategic M&A Talks, Sets May 2024 Deadline for Initial Offers

Centurion Acquisition Corp. Appoints Thomas Vu as Independent Director with Term through 2025

Ocumension Therapeutics Gets China Nod for Phase 3 Trial of Presbyopia Drug

MT Newswires Live

1 Spectacular Growth Stock Down 74% to Buy Hand Over Fist, According to Wall Street

This Artificial Intelligence (AI) Stock Is Up 53% in 2025. Here's How It Could Keep Soaring.

How to Buy Polyswarm (NCT) in 2025

Core & Main Inc : RBC Raises Target Price to $67 From $60

THOMSON REUTERS

MaxCyte Inc. and Ori Biotech Announce Strategic Partnership to Enhance Cell Therapy Manufacturing Efficiency

MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies

THOMSON REUTERS

PYC Therapeutics Says Safety Review Committee Approves Dose Escalation in Autosomal Dominant Optic Atrophy Study

MT Newswires Live

Karat Packaging Inc. Announces Pricing of Secondary Offering of Common Stock

THOMSON REUTERS

Major Shareholder Makes a Big Move with Sprinklr Stock!

Dolly Varden Silver Secures $28.76 Million in Bought-Deal Financing

PYC Therapeutics Advances ADOA Clinical Trial with Dose Escalation Approval

Mark G. Whittenburg, General Counsel and Secretary, Reports Disposal of Common Shares of Core & Main Inc

CEO Alex Shootman Reports Disposal of Common Shares of Alkami Technology Inc

Zip Co Limited Upgrades FY25 Guidance Amid Strong US Performance

Karat Packaging 1.5M share Spot Secondary; price range $27.00-$29.00

Bowman Consulting Announces New Share Repurchase Program

LENZ Therapeutics Holds 2025 Annual Stockholders Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4539/news?page=36"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":728.4047,"timestamp":1750449599999,"preClose":733.55396,"halted":0,"volume":600086043,"delay":0,"changeRate":-0.00702,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-5.149231,"latestTime":"06-20 16:00:00 EDT","open":733.5639,"high":740.8875,"low":721.5701,"amount":21148891571.705418,"amplitude":0.026334,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.831056,"peRate":1446.336174,"turnoverRate":0.045672,"increases":64,"decrements":112,"flats":8,"marketCap":532269657344.75,"floatMarketCap":376169006270.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":740.8875,"amplitude":0.026334,"preClose":733.55396,"low":721.5701,"pbRate":"6.831056","latestPrice":728.4047,"volume":600086043,"delay":0,"open":733.5639,"prevYearClose":648.26935,"prevWeekClose":707.7822,"prevMonthClose":715.6884,"prevQuarterClose":570.2879,"fiveDayClose":724.677,"twentyDayClose":697.4606,"sixtyDayClose":651.8604,"secType":"PLATE","market":"US","turnoverRate":0.045672,"peRate":1446.336174,"marketCap":532269657344.75,"floatMarketCap":376169006270.625,"timestamp":1750449599999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":64,"down":112,"flat":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:36,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542106588","title":"Bridge Investment Group Engages J.P. Morgan and Lazard for Strategic M&A Talks, Sets May 2024 Deadline for Initial Offers","url":"https://stock-news.laohu8.com/highlight/detail?id=2542106588","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542106588?lang=en_us&edition=fundamental","pubTime":"2025-06-11 18:10","pubTimestamp":1749636628,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bridge Investment Group Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL61YfqD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRDG","BK4135","BK4127","BK4539","LAZ"],"gpt_icon":0},{"id":"2542996588","title":"Centurion Acquisition Corp. Appoints Thomas Vu as Independent Director with Term through 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2542996588","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542996588?lang=en_us&edition=fundamental","pubTime":"2025-06-11 18:07","pubTimestamp":1749636438,"startTime":"0","endTime":"0","summary":"Centurion Acquisition Corp. announced the appointment of Thomas Vu to its board of directors as a Class II director with a term expiring at the company's third annual meeting of shareholders. Mr. Vu joins the board as an independent director.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centurion Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL6WgLMW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4539","ALF"],"gpt_icon":0},{"id":"2542091300","title":"Ocumension Therapeutics Gets China Nod for Phase 3 Trial of Presbyopia Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2542091300","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542091300?lang=en_us&edition=fundamental","pubTime":"2025-06-11 17:57","pubTimestamp":1749635838,"startTime":"0","endTime":"0","summary":"China's medical products administrator accepted Ocumension Therapeutics'  phase 3 clinical trial application for its OT-802 pilocarpine hydrochloride drug for presbyopia or loss of focus of the eye.The drug showed a favorable safety profile in preclinical studies, according to a Tuesday filing with the Hong Kong bourse.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01477","BK1191","BK4539","LENZ","BK4007","BK4139","BK1574"],"gpt_icon":0},{"id":"2542518305","title":"1 Spectacular Growth Stock Down 74% to Buy Hand Over Fist, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2542518305","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542518305?lang=en_us&edition=fundamental","pubTime":"2025-06-11 16:12","pubTimestamp":1749629520,"startTime":"0","endTime":"0","summary":"Confluent's data streaming platform helps organizations create live experiences for their customers.Data streaming is becoming a critical piece of the artificial intelligence  revolution, because chatbots require constant access to real-time information.Wall Street analysts are bullish on Confluent stock, and it's trading near the cheapest level in its history.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/06/11/1-growth-stock-down-74-buy-hand-fist-wall-street/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4539","BK4023","CFLT","BK4613","BK4551","BK4588","BK4585"],"gpt_icon":0},{"id":"2542303617","title":"This Artificial Intelligence (AI) Stock Is Up 53% in 2025. Here's How It Could Keep Soaring.","url":"https://stock-news.laohu8.com/highlight/detail?id=2542303617","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542303617?lang=en_us&edition=fundamental","pubTime":"2025-06-11 15:39","pubTimestamp":1749627540,"startTime":"0","endTime":"0","summary":"From the beginning of 2025 through June 9, Duolingo shares outperformed the S&P 500 index by 51%.Duolingo stock has been trading for about 249 times trailing 12-month earnings.Rapid earnings growth expectations make Duolingo stock seem undervalued despite a sky-high price to trailing earnings multiple.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/06/11/this-artificial-intelligence-ai-stock-is-up-53-in/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4204","BK4588","BK4539","BK4023","DUOL","BK4543","BK4613","BK4585","BK4587","BK4551","BK4528"],"gpt_icon":1},{"id":"2542377938","title":"How to Buy Polyswarm (NCT) in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2542377938","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542377938?lang=en_us&edition=fundamental","pubTime":"2025-06-11 14:46","pubTimestamp":1749624362,"startTime":"0","endTime":"0","summary":"Polyswarm  is a decentralized threat detection marketplace where security experts compete to identify threats. As the need for digital security becomes increasingly urgent, more investors may be interested in exploring how to buy NCT. In this guide, we’ll walk you through the steps to buy Polyswarm  safely and efficiently, whether you’re a first-time buyer or a seasoned crypto enthusiast looking to diversify your portfolio. Here’s what you need to know in 2025.You can buy NCT using major exchanges like Coinbase by completing a few simple verification steps.The platform’s unique use of microengines and staking incentivizes early and precise malware identification.In This Guide:How to Buy Polyswarm What is Polyswarm ?Now let’s look at each step in a little more detail.You will also need an exchange that supports the Polyswarm  token. For this guide, we will use Coinbase; however, you can use any exchange you like, as most exchanges have similar processes.","market":"nz","thumbnail":"https://beincrypto.com/wp-content/uploads/2023/06/BIC_hacker_puzzle-covers-850x478.png","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2023/06/BIC_hacker_puzzle-covers-850x478.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/learn/how-to-buy-polyswarm-nct/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4539","BK4551","BK4535","BK4112","BK4585","BK4588","PC","BK4600","LU1861558580.USD","BK4516","LU1861559042.SGD","NCT","BK4596","BK4595","BK4021","BK4209","BK4554"],"gpt_icon":1},{"id":"2542137412","title":"Core & Main Inc : RBC Raises Target Price to $67 From $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2542137412","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542137412?lang=en_us&edition=fundamental","pubTime":"2025-06-11 14:00","pubTimestamp":1749621658,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nFWN3SD02O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4104","LU2089279066.USD","LU2125910179.SGD","CNM","IE0009354923.USD","LU2125910336.SGD","LU2229751404.USD","LU1923621640.USD"],"gpt_icon":0},{"id":"2542744163","title":"MaxCyte Inc. and Ori Biotech Announce Strategic Partnership to Enhance Cell Therapy Manufacturing Efficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2542744163","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542744163?lang=en_us&edition=fundamental","pubTime":"2025-06-11 14:00","pubTimestamp":1749621627,"startTime":"0","endTime":"0","summary":"MaxCyte Inc. has announced a strategic partnership with Ori Biotech to enhance the efficiency, scalability, and productivity of cell therapy manufacturing. The collaboration integrates MaxCyte's ExPERT platform and Flow Electroporation technology with Ori's IRO platform, aiming to optimize gene-edited T cell yield and streamline manufacturing timelines. This joint effort underscores both companies' commitment to advancing cell and gene therapy solutions, ultimately accelerating the availability of transformative treatments for patients globally. The partnership will initially focus on evaluating CD19 CAR expression via CRISPR knock-in in activated T cells.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MaxCyte Inc. published the origin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL1Jfr5Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4121","LU2210149790.SGD","BK4588","LU2095319765.USD","BK4112","LU2210150020.SGD","MXCT","IE00B3QW5Z07.USD","BK4585","BK4539","IE00BGHQF748.EUR","NDAQ"],"gpt_icon":0},{"id":"2542374697","title":"MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2542374697","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542374697?lang=en_us&edition=fundamental","pubTime":"2025-06-11 14:00","pubTimestamp":1749621600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nTUA9R8CPF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","MXCT","BK4539"],"gpt_icon":0},{"id":"2542373795","title":"PYC Therapeutics Says Safety Review Committee Approves Dose Escalation in Autosomal Dominant Optic Atrophy Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2542373795","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542373795?lang=en_us&edition=fundamental","pubTime":"2025-06-11 11:23","pubTimestamp":1749612188,"startTime":"0","endTime":"0","summary":"PYC Therapeutics  said that the safety review committee monitoring the single ascending dose study of its drug candidate PYC-001 for patients with autosomal dominant optic atrophy approved an increase in the dose, according to a Wednesday Australian bourse filing.The committee approved an increase in the dose to be administered to patients in groups two and three to 30 micrograms per eye from 10 micrograms, following an evaluation of four-week follow-up data.The study will be followed by a multiple ascending dose study and an open-label extension study, facilitating repeat dosing and the evaluation of the optimal dosing regimen, safety, tolerability, and efficacy profile.The company's shares shed 1% in recent Wednesday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4007","BK7067","PYC.AU","LENZ","BK4539"],"gpt_icon":0},{"id":"2542320576","title":"Karat Packaging Inc. Announces Pricing of Secondary Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2542320576","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542320576?lang=en_us&edition=fundamental","pubTime":"2025-06-11 10:15","pubTimestamp":1749608130,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nTUA2WCJRH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4104","BK4539","KRT"],"gpt_icon":0},{"id":"2542632060","title":"Major Shareholder Makes a Big Move with Sprinklr Stock!","url":"https://stock-news.laohu8.com/highlight/detail?id=2542632060","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542632060?lang=en_us&edition=fundamental","pubTime":"2025-06-11 10:05","pubTimestamp":1749607512,"startTime":"0","endTime":"0","summary":"New insider activity at Sprinklr ( ($CXM) ) has taken place on June 10, 2025. Significant shareholder R David Tabors has recently sold 84,010 share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-shareholder-makes-a-big-move-with-sprinklr-stock-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-shareholder-makes-a-big-move-with-sprinklr-stock-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","BK4539","CXM"],"gpt_icon":0},{"id":"2542332942","title":"Dolly Varden Silver Secures $28.76 Million in Bought-Deal Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2542332942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542332942?lang=en_us&edition=fundamental","pubTime":"2025-06-11 08:32","pubTimestamp":1749601938,"startTime":"0","endTime":"0","summary":"Dolly Varden Silver ( ($TSE:DV) ) has shared an announcement. Dolly Varden Silver Corporation announced the full exercise of the underwriters’ opti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dolly-varden-silver-secures-28-76-million-in-bought-deal-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dolly-varden-silver-secures-28-76-million-in-bought-deal-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4009","BK4023","DV"],"gpt_icon":0},{"id":"2542532671","title":"PYC Therapeutics Advances ADOA Clinical Trial with Dose Escalation Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2542532671","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542532671?lang=en_us&edition=fundamental","pubTime":"2025-06-11 08:12","pubTimestamp":1749600776,"startTime":"0","endTime":"0","summary":"PYC Therapeutics Limited ( ($AU:PYC) ) has provided an announcement. PYC Therapeutics has received approval from the Safety Review Committee to esc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-advances-adoa-clinical-trial-with-dose-escalation-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-advances-adoa-clinical-trial-with-dose-escalation-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2542332591","title":"Mark G. Whittenburg, General Counsel and Secretary, Reports Disposal of Common Shares of Core & Main Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2542332591","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542332591?lang=en_us&edition=fundamental","pubTime":"2025-06-11 07:24","pubTimestamp":1749597842,"startTime":"0","endTime":"0","summary":"Mark G. Whittenburg, General Counsel and Secretary of Core & Main Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core & Main Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL8r9n5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4104","LU2229751404.USD","LU2125910336.SGD","IE0009354923.USD","LU2125910179.SGD","CNM","LU1923621640.USD","LU2089279066.USD"],"gpt_icon":0},{"id":"2542325685","title":"CEO Alex Shootman Reports Disposal of Common Shares of Alkami Technology Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2542325685","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542325685?lang=en_us&edition=fundamental","pubTime":"2025-06-11 07:15","pubTimestamp":1749597302,"startTime":"0","endTime":"0","summary":"Alex Shootman, Chief Executive Officer of Alkami Technology Inc, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkami Technology Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL4BlTjl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CEO Alex Shootman Reports Disposal of Common Shares of Alkami Technology Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4023","ALKT"],"gpt_icon":0},{"id":"2542230053","title":"Zip Co Limited Upgrades FY25 Guidance Amid Strong US Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=2542230053","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542230053?lang=en_us&edition=fundamental","pubTime":"2025-06-11 06:57","pubTimestamp":1749596279,"startTime":"0","endTime":"0","summary":"Zip Co Ltd. ( ($AU:ZIP) ) has issued an announcement. Zip Co Limited has upgraded its FY25 guidance following strong performance, particularly in t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zip-co-limited-upgrades-fy25-guidance-amid-strong-us-performance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zip-co-limited-upgrades-fy25-guidance-amid-strong-us-performance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4077","BK4539","ZIP"],"gpt_icon":0},{"id":"2542280603","title":"Karat Packaging 1.5M share Spot Secondary; price range $27.00-$29.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2542280603","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542280603?lang=en_us&edition=fundamental","pubTime":"2025-06-11 05:55","pubTimestamp":1749592507,"startTime":"0","endTime":"0","summary":"BofA and William Blair are acting as joint book running managers for the offering. Published first on TheFly – the ultimate source for real-time, m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/karat-packaging-1-5m-share-spot-secondary-price-range-27-00-29-00-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/karat-packaging-1-5m-share-spot-secondary-price-range-27-00-29-00-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4104","BK4539","KRT"],"gpt_icon":0},{"id":"2542328463","title":"Bowman Consulting Announces New Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2542328463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542328463?lang=en_us&edition=fundamental","pubTime":"2025-06-11 05:31","pubTimestamp":1749591077,"startTime":"0","endTime":"0","summary":"Bowman Consulting Group ( ($BWMN) ) has issued an update. On June 6, 2025, Bowman Consulting Group announced a new share repurchase program, allowi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bowman-consulting-announces-new-share-repurchase-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bowman-consulting-announces-new-share-repurchase-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BWMN","BK4129"],"gpt_icon":0},{"id":"2542553328","title":"LENZ Therapeutics Holds 2025 Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542553328","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542553328?lang=en_us&edition=fundamental","pubTime":"2025-06-11 05:18","pubTimestamp":1749590337,"startTime":"0","endTime":"0","summary":"The latest update is out from LENZ Therapeutics ( ($LENZ) ). LENZ Therapeutics, Inc. held its 2025 annual meeting of stockholders on June 10, 2025....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lenz-therapeutics-holds-2025-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lenz-therapeutics-holds-2025-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","LENZ","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":47,"pageCount":36,"totalSize":932,"code":"91000000","status":"200"}]}}